Drug Type Small molecule drug |
Synonyms MK 6592, VX-667 |
Target |
Action inhibitors |
Mechanism AURK inhibitors(Serine/threonine-protein kinase Aurora inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H26ClF2N7O2 |
InChIKeySLUHYAXFRJQTGB-KRWDZBQOSA-N |
CAS Registry937276-52-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | - | 01 Dec 2006 | |
Solid tumor | Phase 1 | United States | - |